bioRxivGenomicsPreprint
Discovering chromatin dysregulation induced by protein-coding perturbations at scale
Max P. C. FrenkeliD, Margaux L.A. HujoeliD, Zachary Scott MorrisiD, Srivatsan RamaniD
Abstract
Although population-scale databases have expanded to millions of protein-coding variants, insight into variant mechanisms has not kept pace. We present PROD-ATAC, a high-throughput method for discovering the effects of protein-coding variants on chromatin. A pooled library of variants is expressed in a disease-agnostic cell line, and single-cell ATAC resolves each variants effect on chromatin. Using PROD-ATAC, we characterized the effects of >100 oncofusions (a class of cancer-causing chimeric proteins) and controls and revealed that pioneer activity is a common feature of fusions spanning an enormous range of fusion frequencies. Further, fusion-induced dysregulation can be context-agnostic as observed mechanisms often overlapped with cancer and cell-type specific prior knowledge. We also showed that gain-of-function pioneering is common among oncofusions. This work provides a global view of fusion-induced chromatin. We uncovered convergent mechanisms among disparate oncofusions and shared modes of dysregulation across different cancers. PROD-ATAC is generalizable to any set of protein-coding variants.
- organism: human
- assay: scATAC-seq
- research focus: variant effect prediction
- research focus: gene regulatory network inference
- research focus: benchmarking
- research focus: software / tool
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic integration of protein affecting mutations, gene fusions, and copy number alterations into a comprehensive somatic mutational profile
Shawn S Striker, Sierra F. Wilferd, … Christopher L. Plaisier·Cell Reports MethodsPeer-reviewed·Apr 1, 2023
- Human Transcription Factor and Protein Kinase Gene Fusions in Human Cancer
Kari Salokas, Rigbe G. Weldatsadik, Markku T Varjosalo·Scientific ReportsPeer-reviewed·Aug 25, 2020
- Evaluation of the gene fusion landscape in early onset sporadic rectal cancer reveals association with chromatin architecture and genome stability
Asmita Gupta, Sumedha Avadhanula, Murali Dharan Bashyam·OncogenePeer-reviewed·Jun 27, 2024
- TumorFusions: an integrative resource for reporting cancer-associated transcript fusions in 33 tumor types
X. Hu, Q. Wang, … R. Verhaak·bioRxiv·Jul 11, 2017
- Chromatin accessibility analysis uncovers regulatory element landscape in prostate cancer progression
J. Uusi-Mäkelä, E. Afyounian, … M. Nykter·bioRxiv·Sep 8, 2020
- Genomic foundation model-derived disruption profiling links somatic mutations to cancer biology and clinical outcomes
Akshatha Nayak, Tae-Rim Lee, … Ilias Georgakopoulos‐Soares·medRxiv·Sep 16, 2026